Sotera Health (SHC) Stock
Global sterilization and testing for medical and pharmaceuticals. Here's the price, business snapshot, and what's worth knowing about Sotera Health in June 2026.
Sotera Health Co (SHC) is a global provider of mission‑critical sterilisation, laboratory testing and advisory services for healthcare, medical device and pharmaceutical customers. The business helps clients meet regulatory and safety standards through sterilisation, microbiology and analytical testing, plus validation and consulting. Revenue is influenced by device and pharmaceutical volumes, regulatory inspections and long‑term service contracts; capital expenditure is needed to maintain and expand facilities. Key growth drivers include medical device demand, regulatory tightening and geographic expansion, while risks include contamination or regulatory incidents, pricing pressure, capacity constraints and customer concentration. Market capitalisation is around $4.72bn. This is general educational information only, not personal investment advice. Values can rise or fall, and investors should check current filings, financials and market data before making decisions.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Sotera Health's stock with a target price of $14.75, indicating growth potential.
Financial Health
Sotera Health is showing strong revenue and profits, indicating good financial performance over the past year.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
AERCAP HOLDINGS N.V.
AerCap Holdings N.V. is an aircraft leasing company based in Ireland.
BROADRIDGE FINANCIAL SOLUTION INC
Broadridge Financial Solutions, Inc. is a company that provides data and analytics solutions and technology services to the financial services industry.
BRINK'S COMPANY
Global security services provider.
Baskets Featuring SHC
Food Safety Stocks: What's Next After Costco Lawsuit
A recent lawsuit against Costco regarding salmonella in its rotisserie chicken has intensified focus on food safety across the grocery industry. This creates a potential investment opportunity in companies that provide testing, diagnostics, and supply chain verification services.
Published: 15 February 2026
Explore BasketFood Safety Investing: The Next Chapter Unfolds
Recent recalls of baby formula by Danone and other major brands, traced back to a single contaminated ingredient supplier, have exposed significant risks in the global supply chain. This situation creates a potential investment opportunity in companies focused on food safety, testing, and alternative brands with more secure sourcing.
Published: 24 January 2026
Explore BasketSpecialist's Toolkit
Discover companies that provide mission-critical tools and technologies professionals can't work without. These carefully selected stocks represent businesses with strong competitive advantages due to their irreplaceable products and services that power industries from biotech to aerospace.
Published: 17 June 2025
Explore BasketWhy You’ll Want to Watch This Stock
Regulated healthcare demand
Demand links to medical device and pharma growth and tighter regulation, which can support steady service volumes — though performance can vary and incidents may occur.
Global service footprint
A worldwide network helps serve multinational customers and diversify revenue, but adds operational complexity and exposure to regional regulatory differences.
Capital and technology
Investments in facilities and sterilisation technology are necessary for compliance and growth; these are capital‑intensive and can affect margins and cash flow.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
